Inventor
VOLANTE RALPH P
US65 patents
⚠️ This page may combine multiple inventors who share the name “VOLANTE RALPH P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
48 patentsUS4582915AApr 15, 1986
Process for C-methylation of 2-methylbutyrates
MERCK & CO INC61 citations96
US5614632AMar 25, 1997
Process for the preparation of leukotriene anatgonists
MERCK & CO INC100 citations95
US4611067ASep 9, 1986
Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
MERCK & CO INC57 citations95
US6320052B1Nov 20, 2001
Process for the preparation of leukotriene antagonists
MERCK & CO INC51 citations93
US6130334AOct 10, 2000
Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
MERCK & CO INC25 citations91
US5883267AMar 16, 1999
Process for making phenyl heterocycles useful as cox-2 inhibitors
MERCK & CO INC23 citations91
US5290941AMar 1, 1994
Facile condensation of methylbenzoxazoles with aromatic aldehydes
MERCK & CO INC45 citations91
US6127545AOct 3, 2000
Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
MERCK & CO INC30 citations90
US5723616AMar 3, 1998
Process for the preparation of a growth hormone secretagogue
MERCK & CO INC24 citations88
US6143885ANov 7, 2000
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC18 citations84
US4374772AFeb 22, 1983
Process for the preparation of N-formimidoyl thienamycin and reagents therefor
MERCK & CO INC24 citations81
US4940803AJul 10, 1990
Process for synthesis of 1R,2R,5R-2-hydroxy-6-oxo-7-oxabicyclo[3.2.1]-octane
MERCK & CO INC10 citations74
US4920218AApr 24, 1990
Novel hydroxide mediated FK-506 rearrangement process
MERCK & CO INC10 citations74
US4584389AApr 22, 1986
Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
MERCK & CO INC9 citations74
US5874629AFeb 23, 1999
Chiral bisphosphines
MERCK & CO INC11 citations73
US5723615AMar 3, 1998
Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
MERCK & CO INC7 citations73
US5618939AApr 8, 1997
Process for making HIV protease inhibitors
MERCK & CO INC4 citations73
US5612484AMar 18, 1997
Process for making HIV protease inhibitors
MERCK & CO INC12 citations73
US5463067AOct 31, 1995
Process for making HIV protease inhibitors
MERCK & CO INC11 citations73
US5446158AAug 29, 1995
Process for synthesis of FK-506 and tricarbonyl intermediates
MERCK & CO INC7 citations73
US6153787ANov 28, 2000
Intermediates for making heterocycles useful as COX-2 inhibitors
MERCK & CO INC13 citations72
US5728840AMar 17, 1998
Process for making an epoxide
MERCK & CO INC7 citations72
US4466914AAug 21, 1984
Process for the conversion of primary and secondary alcohols to their corresponding thiols and thiol esters
MERCK & CO INC7 citations72
US6071916AJun 6, 2000
HIV protease inhibitor
MERCK & CO INC12 citations71
US5059696AOct 22, 1991
Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
MERCK & CO INC7 citations71
US5493018AFeb 20, 1996
Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid
MERCK & CO INC7 citations68
US5654424AAug 5, 1997
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC2 citations63
US5087703AFeb 11, 1992
Process for synthesis of FK-506 intermediates
MERCK & CO INC2 citations63
US4980466ADec 25, 1990
Hydroxide mediated FK-506 rearrangement product
MERCK & CO INC2 citations63
US4914220AApr 3, 1990
Process for synthesis of E-2-methyl-α,β-unsaturated aldehydes
MERCK & CO INC6 citations63
US4611081ASep 9, 1986
Process for the preparation of HMG-CoA reductase inhibitors intermediates
MERCK & CO INC5 citations63
US6043387AMar 28, 2000
Chiral bisphosphines
MERCK & CO INC4 citations62
US5637711AJun 10, 1997
Process for making HIV protease inhibitors
MERCK & CO INC3 citations62
US5496948AMar 5, 1996
Process for making HIV protease inhibitors
MERCK & CO INC3 citations62
US5491238AFeb 13, 1996
Process for making HIV protease inhibitors
MERCK & CO INC5 citations62
US4952288AAug 28, 1990
Process for the preparation of 4-acyloxyazetidin-2-one by electrochemical methods
MERCK & CO INC5 citations62
US4942235AJul 17, 1990
Process for certain (2R-trans)hexahydroaroquinolizines
MERCK & CO INC3 citations62
US4940520AJul 10, 1990
Process for the preparation of 4-acyloxyazetidin-2-one by singlet oxygen oxidation
MERCK & CO INC5 citations62
US4923982AMay 8, 1990
Oxidation and reduction method to produce 4-acyloxyazetidin-2-one
MERCK & CO INC3 citations62
US4582914AApr 15, 1986
Process for the preparation of HMG-CoA reductase inhibitors
MERCK & CO INC3 citations62
US5618937AApr 8, 1997
Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide
MERCK & CO INC5 citations61
US7368569B2May 6, 2008
Process for making spirolactone compounds
MERCK & CO INC2 citations60
US5426230AJun 20, 1995
Process for the preparation of 4-chloro-2-cyclopropylcarbonylaniline
MERCK & CO INC4 citations60
US5380849AJan 10, 1995
Process for optically pure decahydroisoqiunolines
MERCK & CO INC2 citations60
US5808082ASep 15, 1998
Method of preparing phosphodiesterase IV inhibitors
MERCK & CO INC2 citations59
US5650523AJul 22, 1997
Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
MERCK & CO INC5 citations59
US5235066AAug 10, 1993
FK-506 type macrolide intermediate
MERCK & CO INC3 citations59
US6479672B1Nov 12, 2002
Diastereoselective preparation of Michael adducts
MERCK & CO INC2 citations58
MERCK & CO LTD
1 patent(unassigned)
1 patentShowing the top 50 of 65 patents by PatentIndex Score.